Kaytross Acg Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 08-12-2024
- Paid Up Capital ₹ 7.50 M
as on 08-12-2024
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 3.50 Cr
as on 08-12-2024
- Satisfied Charges ₹ 5.00 Cr
as on 08-12-2024
- Revenue -47.08%
(FY 2020)
- Profit -1.88%
(FY 2020)
- Ebitda -9.06%
(FY 2020)
- Net Worth -131.88%
(FY 2020)
- Total Assets -46.57%
(FY 2020)
About Kaytross Acg Lifesciences
The Corporate was formerly known as Kaytross Acg Lifesciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹3.50 Cr. The company has closed loans amounting to ₹5.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Chetan Patni, Arvind Shivasharan, and Aparna Patni serve as directors at the Company.
- CIN/LLPIN
U24119MH2007PLC171416
- Company No.
171416
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
07 Jun 2007
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Kaytross Acg Lifesciences Limited offer?
Kaytross Acg Lifesciences Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Pain Relief Spray.
Who are the key members and board of directors at Kaytross Acg Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chetan Patni  | Director | 07-Jun-2007 | Current |
| Arvind Shivasharan | Director | 07-Jun-2007 | Current |
| Aparna Patni | Director | 12-May-2017 | Current |
Financial Performance of Kaytross Acg Lifesciences.
Kaytross Acg Lifesciences Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 47.08% decrease. The company also saw a slight decrease in profitability, with a 1.88% decrease in profit. The company's net worth observed a substantial decline by a decrease of 131.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kaytross Acg Lifesciences?
In 2019, Kaytross Acg Lifesciences had a promoter holding of 99.87% and a public holding of 0.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Nov 2016 | ₹1.00 Cr | Open |
Others Creation Date: 09 Nov 2016 | ₹2.50 Cr | Open |
The Saraswat Co-Op. Bank Ltd. Creation Date: 03 Feb 2012 | ₹3.00 M | Satisfied |
How Many Employees Work at Kaytross Acg Lifesciences?
Kaytross Acg Lifesciences has a workforce of 25 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kaytross Acg Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kaytross Acg Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
